Page last updated: 2024-08-23

du-21220 and cefotetan

du-21220 has been researched along with cefotetan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Curto, C; Sbracia, M; Scarpellini, F; Scarpellini, L1

Trials

1 trial(s) available for du-21220 and cefotetan

ArticleYear
Effectiveness of a cephalosporin, cefotetan, in inhibition of uterine matrix metalloproteinases by a non-antibacterial mechanism.
    Annals of the New York Academy of Sciences, 1994, Sep-06, Volume: 732

    Topics: alpha 1-Antitrypsin; Biomarkers; CA-125 Antigen; Cefotetan; Female; Fetal Membranes, Premature Rupture; Fibronectins; Glycosaminoglycans; Humans; Hydroxyproline; Metalloendopeptidases; Pregnancy; Pregnancy Trimester, Second; Ritodrine; Uterus

1994

Other Studies

2 other study(ies) available for du-21220 and cefotetan

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008